205 related articles for article (PubMed ID: 23884783)
1. Clinical review: Treatment of neurohypophyseal diabetes insipidus.
Oiso Y; Robertson GL; Nørgaard JP; Juul KV
J Clin Endocrinol Metab; 2013 Oct; 98(10):3958-67. PubMed ID: 23884783
[TBL] [Abstract][Full Text] [Related]
2. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants.
Korkmaz HA; Demir K; Kılıç FK; Terek D; Arslanoğlu S; Dizdarer C; Ozkan B
J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):923-7. PubMed ID: 24854529
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study.
Arima H; Oiso Y; Juul KV; Nørgaard JP
Endocr J; 2013; 60(9):1085-94. PubMed ID: 23811987
[TBL] [Abstract][Full Text] [Related]
4. Buccally Administered Intranasal Desmopressin Acetate for the Treatment of Neurogenic Diabetes Insipidus in Infancy.
Smego AR; Backeljauw P; Gutmark-Little I
J Clin Endocrinol Metab; 2016 May; 101(5):2084-8. PubMed ID: 27011115
[TBL] [Abstract][Full Text] [Related]
5. Variability in Oral Desmopressin Dose Requirements in Children with Central Diabetes Insipidus.
Almutlaq N; Eugster EA
J Pediatr; 2021 Dec; 239():228-230. PubMed ID: 34487771
[TBL] [Abstract][Full Text] [Related]
6. [Persistent central diabetes insipidus in a very low birth weight infant].
Quetin F; Garnier H; Brauner R; Vodovar M; Magny JF
Arch Pediatr; 2007 Nov; 14(11):1321-3. PubMed ID: 17916426
[TBL] [Abstract][Full Text] [Related]
7. Comparison of incidence of hyponatremia between intranasal and oral desmopressin in patients with central diabetes insipidus.
Kataoka Y; Nishida S; Hirakawa A; Oiso Y; Arima H
Endocr J; 2015; 62(2):195-200. PubMed ID: 25382102
[TBL] [Abstract][Full Text] [Related]
8. Desmopressin duration of antidiuretic action in patients with central diabetes insipidus.
Juul KV; Bichet DG; Nørgaard JP
Endocrine; 2011 Aug; 40(1):67-74. PubMed ID: 21626284
[TBL] [Abstract][Full Text] [Related]
9. Dipsogenic diabetes insipidus: report of a novel treatment strategy and literature review.
Perkins RM; Yuan CM; Welch PG
Clin Exp Nephrol; 2006 Mar; 10(1):63-7. PubMed ID: 16544179
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of a tertiary center enuresis population, with special emphasis on the relation among nocturnal diuresis, functional bladder capacity and desmopressin response.
Dehoorne JL; Walle CV; Vansintjan P; Raes AM; De Guchtenaere AR; Van Laecke E; Hoebeke P; Vande Walle JG
J Urol; 2007 Mar; 177(3):1130-7. PubMed ID: 17296432
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of oral desmopressin therapy in posterior urethral valve patients with polyuria and detection of factors affecting the therapy.
Naghizadeh S; Kefi A; Dogan HS; Burgu B; Akdogan B; Tekgul S
Eur Urol; 2005 Nov; 48(5):819-25. PubMed ID: 15998564
[TBL] [Abstract][Full Text] [Related]
12. Use of desmopressin eye drops in the treatment of equine congenital central diabetes insipidus.
Kranenburg LC; Thelen MH; Westermann CM; de Graaf-Roelfsema E; van der Kolk JH
Vet Rec; 2010 Nov; 167(20):790-1. PubMed ID: 21262613
[No Abstract] [Full Text] [Related]
13. The management of central diabetes insipidus in infancy: desmopressin, low renal solute load formula, thiazide diuretics.
Rivkees SA; Dunbar N; Wilson TA
J Pediatr Endocrinol Metab; 2007 Apr; 20(4):459-69. PubMed ID: 17550208
[TBL] [Abstract][Full Text] [Related]
14. Profound hypernatremia due to central diabetes insipidus.
Vaqar A; Rafiq A; Javaid KH; Parveen R; Sadaf R
J Coll Physicians Surg Pak; 2012 Jun; 22(6):409-11. PubMed ID: 22630107
[TBL] [Abstract][Full Text] [Related]
15. Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations.
Kim RJ; Malattia C; Allen M; Moshang T; Maghnie M
Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():115-23. PubMed ID: 16456490
[TBL] [Abstract][Full Text] [Related]
16. Neurosarcoidosis-associated central diabetes insipidus masked by adrenal insufficiency.
Non L; Brito D; Anastasopoulou C
BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25612752
[TBL] [Abstract][Full Text] [Related]
17. A patient with essential hypernatremia had good response to desmopressin acetate therapy.
Guo Q; Lu J; Mu Y; Dou J; Pan C
Neuro Endocrinol Lett; 2010; 31(5):588-93. PubMed ID: 21173753
[TBL] [Abstract][Full Text] [Related]
18. The effect of desmopressin on renal water and solute handling in desmopressin resistant monosymptomatic nocturnal enuresis.
Kamperis K; Rittig S; Radvanska E; Jørgensen KA; Djurhuus JC
J Urol; 2008 Aug; 180(2):707-13; discussion 713-4. PubMed ID: 18554642
[TBL] [Abstract][Full Text] [Related]
19. [Nocturnal polyuria, treatment with desmopressin].
Zachoval R; Krhut J; Šottner O; Hanuš T; Martan A; Horčička L; Feyereisl J; Halaška M; Švabík K; Krofta L
Ceska Gynekol; 2013 Aug; 78(4):385-9. PubMed ID: 24040989
[TBL] [Abstract][Full Text] [Related]
20. Long-term hormone replacement treatment in a horse with central diabetes insipidus.
Durie I; van Galen G
J Vet Intern Med; 2020 Mar; 34(2):1013-1017. PubMed ID: 31960998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
